TITLE

The role of Mycobacterium tuberculosis Rv3166c protein-derived high-activity binding peptides in inhibiting invasion of human cell lines

AUTHOR(S)
Ocampo, Marisol; Aristizábal-Ramírez, Daniel; Rodríguez, Diana M.; Muñoz, Marina; Curtidor, Hernando; Vanegas, Magnolia; Patarroyo, Manuel A.; Patarroyo, Manuel E.
PUB. DATE
May 2012
SOURCE
PEDS: Protein Engineering, Design & Selection;May2012, Vol. 25 Issue 5, p235
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Given the urgent need for designing a new antituberculosis vaccine conferring total protection on patients of all ages, following the line of research adopted by our institute, this work has identified Mycobacterium tuberculosis (Mtb) Rv3166c protein high-activity binding peptides (HABPs) which are able to inhibit bacterial invasion of U937 (monocyte-derived macrophages) and A549 (type II alveolar epithelial cells) cell lines. The presence and transcription of the rv3166c gene in the Mtb species complex was confirmed by polymerase chain reaction (PCR) and reverse transcriptase-PCR; Rv3166c expression was evaluated by western blot and cellular localisation confirmed by immunoelectron microscopy. Its presence was mainly determined on cell surface. Sixteen peptides covering its entire length were chemically synthesised and tested for their ability to bind to U937 and A549 cells. Two U937 HABPs were identified and three for A549, one of them being shared by both cell lines. The four HABPs found inhibited Mtb entry by 15.07–94.06%. These results led us to including Rv3166c HABPs as candidates for further studies contributing towards the search for a multiepitope, chemically synthesised, subunit-based antituberculosis vaccine.
ACCESSION #
75054734

 

Related Articles

  • Central Memory CD4+ T Cells Are Responsible for the Recombinant Bacillus Calmette-Guérin ΔureC::hly Vaccine's Superior Protection Against Tuberculosis. Vogelzang, Alexis; Perdomo, Carolina; Zedler, Ulrike; Kuhlmann, Stefanie; Hurwitz, Robert; Gengenbacher, Martin; Kaufmann, Stefan H. E. // Journal of Infectious Diseases;Dec2014, Vol. 210 Issue 12, p1928 

    Bacillus Calmette-Guérin (BCG) has been used for vaccination against tuberculosis for nearly a century. Here, we analyze immunity induced by a live tuberculosis vaccine candidate, recombinant BCG ΔureC::hly vaccine (rBCG), with proven preclinical and clinical safety and immunogenicity. We...

  • Evaluation of Substituted Benzaldehydes Against Mycobacterium tuberculosis. de Lima Ferreira, Marcelle; Candéa, André Luis Peixoto; de Oliveira Henriques, Maria das Graças Muller; Lourenço, Maria Cristina Silva; Kaiser, Carlos Roland; de Souza, Marcus Vinicius Nora // Letters in Drug Design & Discovery;Dec2010, Vol. 7 Issue 10, p754 

    No abstract available.

  • SYNTHESIS AND STUDY OF SOME PYRAZOLE DERIVATIVES AS ANTI TUBERCULAR AGENT. Patel, Vimal I.; Patel, Bhavesh // International Journal of Pharma & Bio Sciences;Oct-Dec2010, Vol. 1 Issue 4, pP453 

    The present work deals with evaluation of anti-tubercular activity of various aldehyde derivatives synthesized by Claisen-Schmidt condensation method. The formation of pyrazole derivatives by reaction with phenyl isothiocyanate was also attempted. The synthesized derivatives were screened for...

  • An Approach for the Rational Design of New Antituberculosis Agents. Pasqualoto, K.F.M.; Ferreira, E.I. // Current Drug Targets;Dec2001, Vol. 2 Issue 4, p427 

    Tuberculosis (TB) kills more youth and adults than any other infectious disease in the world today. The emergence of new strains of Mycobacterium tuberculosis resistant to some or all current antituberculosis drugs is a serious and crescent problem. The resistance is often a corollary to HIV...

  • Antitubercular Properties of Substituted Hydroxycyclohexadienones. Shah, Manish; Wells, Geoffrey; Bradshaw, Tracey D.; Laughton, Charles A.; Stevens, Malcolm F.G.; Westwell, Andrew D. // Letters in Drug Design & Discovery;Aug2006, Vol. 3 Issue 6, p419 

    The in vitro evaluation of a series of (hetero)aromatic-substituted 4-hydroxycyclohexa-2,5-dienones (quinols) and analogues against M. tuberculosis is reported. The most active compound in the series was found to be 4-(benzothiazol-2-yl)-4-hydroxycyclohexa-2,5-dienone 1a with a minimum...

  • Antitubercular pharmacodynamics of phenothiazines. Warman, Ashley J.; Rito, Teresa S.; Fisher, Nicholas E.; Moss, Darren M.; Berry, Neil G.; O'Neill, Paul M.; Ward, Stephen A.; Biagini, Giancarlo A. // Journal of Antimicrobial Chemotherapy (JAC);Apr2013, Vol. 68 Issue 4, p869 

    Objectives Phenothiazines have been shown to exhibit in vitro and in vivo activity against Mycobacterium tuberculosis (Mtb) and multidrug-resistant Mtb. They are predicted to target the genetically validated respiratory chain component type II NADH:quinone oxidoreductase (Ndh). Using a set of...

  • Synthesis and antituberculosis activity of derivatives of the diterpenoid isosteviol with azine, hydrazide, and hydrazone moieties. Garifullin, B. F.; Strobykina, I. Yu.; Mordovskoi, G. G.; Mironov, V. F.; Kataev, V. E. // Chemistry of Natural Compounds;Mar2011, Vol. 47 Issue 1, p55 

    Derivatives of the diterpenoid isosteviol (16-oxo- ent-beyeran-19-oic acid) with azine, hydrazone, and hydrazide moieties were synthesized. They exhibited high tuberculostatic activity in vitro against the strain Mycobacterium tuberculosis HR (minimum inhibiting concentration in the range...

  • Effects of low incubation temperatures on the bactericidal activity of anti-tuberculosis drugs. Coleman, David; Waddell, Simon J.; Mitchison, Denis A. // Journal of Antimicrobial Chemotherapy (JAC);Jan2011, Vol. 66 Issue 1, p146 

    Objectives To explore the effect of low incubation temperatures and the consequent slowing of bacterial metabolism on the bactericidal action of anti-tuberculosis drugs against Mycobacterium tuberculosis. Methods Counting of surviving bacteria during exposure of static cultures to 1 mg/L...

  • Synthesis, antituberculosis activity and QSAR study of some novel 2-(nitroaryl)-5-(nitrobenzylsulfinyl and sulfonyl)-1,3,4-thiadiazole derivatives. A., Foroumadi; A., Sakhteman; Z., Sharifzadeh; N., Mohammadhosseini; B., Hemmateenejad; M. H., Moshafi; M., Vosooghi; M., Amini; A., Shafiee // DARU;2007, Vol. 15 Issue 4, p218 

    Background and the purpose of the study: In continuation of our research program for new antitubercular agents, some hybrid compounds containing a 5-nitrohetrocyle and 1,3,4-thiadiazole ring have been synthesized and their antituberculosis activity have been evaluated. QSAR studies were...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics